TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors.
Pharmacol Res. 2021 Nov;173:105911. doi: 10.1016/j.phrs.2021.105911. Epub 2021 Sep 22.
Pharmacol Res. 2021.
PMID: 34560251
Free PMC article.